Author

G. Raverot

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Long-term Safety and Efficacy of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: Results From a 52-Week Open-Label Extension Trial.

OBJECTIVE To evaluate long-term safety and efficacy of once-weekly lonapegsomatropin in adults with growth hormone (GH) deficiency. METHODS This 52-week, multicenter, open-label extension trial enrolled adults with GH deficiency who completed the 38-week phase 3 foresiGHt trial, in which participants received lonapeg...

B. Biller, A. Gilis-Januszewska, M. Doknic et al. · Endocrine Practice · 0 citations

Review Open access Sep 2026

Treatment of growth hormone deficiency with long-acting growth hormones in children, adolescents and adults: Clinical evidence and practical considerations.

The review discusses practical aspects of dosing and monitoring across age groups and addresses use in special populations and during the transition period from paediatric to adult care, including patient preference and the impact on metabolism, bone health and muscle strength.

Agnès Linglart, Régis Coutant, V. Kerlan et al. · Annales d'Endocrinologie · 0 citations